tirzepatide & semaglutide Shows Superior Weight Loss Over in Phase 3 Trial Tirzepatide vs Semaglutide: What's the

Detournay, O

What the Evidence Actually Shows The efficacy signal for semaglutide in weight management is unusually strong for pharmacology, and it is worth being precise about what kind of evidence it is

Serious adverse events were reported more in the semaglutide group than in the placebo group

Given that thyroid cancer is mentioned in the product label as a potential adverse event, spontaneous reporting might have been driven by physician and public awareness. The researchers said more studies are needed to examine thyroid cancer risk over a longer follow-up period and to assess risk for individual drugs.

Keep in mind that not everyone experiences negative side effects

Initial side effects like mild nausea usually appear first and resolve as your system adapts